Passage Bio, Inc. (PASG)

4.75 -0.29 (-5.75%) USD  |  NASDAQ  |  Sep 18, 16:00
4.70 -0.05 (-1.05%) After-Hours: 20:00
More

Passage Bio Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for PASG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 10, 2026 --
June 10, 2026 --
May 12, 2026 --
April 24, 2026 --
April 21, 2026 --
March 30, 2026 --
March 03, 2026 --
November 24, 2025 --
November 18, 2025 --
November 11, 2025 --
October 08, 2025 --
August 13, 2025 --
May 19, 2025 --
May 14, 2025 --
May 13, 2025 --
March 04, 2025 --
Date Value
December 03, 2024 --
October 07, 2024 --
August 08, 2024 --
August 01, 2024 --
May 14, 2024 --
March 04, 2024 --
December 20, 2023 --
December 11, 2023 --
November 13, 2023 --
August 07, 2023 --
July 22, 2023 --
June 29, 2023 --
May 11, 2023 --
April 14, 2023 --
March 07, 2023 --
March 06, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
ARS Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade